At the FY 2023 Annual General Meeting, Altium (ASX: ALU) highlighted its focus on penetrating the enterprise market.

The FY 2023 Pro Medicus (ASX: PME) AGM further demonstrated the high quality of the business and the good nature of the leadership group.

The AGM was a good opportunity to catch up with company leadership and other shareholders.

Maxiparts (ASX: MXI) is on another acquisition hunt, vacuuming two businesses. One seems to be a great business but is it a sound investment?

Chrysos Corporation (ASX: C79) is emerging as a fast growing disruptor in a growing industry. Here’s why its watchlist worthy.

Hitech Group Australia (ASX: HIT) has achieved epic earnings growth over the past few years; and pays a decent dividend yield to boot.

3 ASX stocks are in the running to win the Australian Exporter of the Year for 2023. Are these ASX stocks on the cusp of greatness or major disappointment?

Here are some of the small-cap Annual General Meetings coming up this month.

The Nanosonics (ASX: NAN) AGM reveals challenging conditions for the hospital industry but management is buoyed by CORIS progress.

The Mader (ASX: MAD) update for Q1 FY2024 showed strong momentum however at current share price levels, is it a sound investment?

The Adore Beauty (ASX: ABY) trading update for Q1 FY2024 shows promise but is it capable of becoming more than a mediocre business in the long run?

DUG Technology (ASX: DUG) posted strong results in Q1 FY2024, but is this down to the business or external factors?

There are definitely better opportunities in small-caps after the last 18 months, but I’m still leaning cautious due to inflation.

3 ASX retail stocks reveal falling sales in their trading updates for Q1 FY 2024 but investors should keep an eye on one retailer.

Playside Studios (ASX: PLY) reports record quarterly revenue with growth from the higher margin Original IP division driving the growth.

Ansarada (ASX: AND) is a genuine software business, but the challenge is that demand is potentially quite cyclical.

Spacetalk (ASX: SPA) delivered strong revenue growth in Q1 FY 2024 but investors should pay closer attention to its financial health.

RPM Global (ASX: RUL) will institute investor presentations after their results, including allowing shareholders to ask questions.

Cettire (ASX: CTT) reported rapid growth in quarterly sales in Q1 FY 2024 but questions remain over scalability.

Both RPM Global (ASX: RUL) and SRG Global (ASX: SRG) are reporting strong demand from their mining clients.